Alteration of Transcriptomic Profile and Antiseptic Efficacy of Adipose-Derived Mesenchymal Stromal/Stem Cells Under Different Culture Conditions
- 1 February 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Stem Cells and Development
- Vol. 32 (3-4), 75-86
- https://doi.org/10.1089/scd.2022.0238
Abstract
Mesenchymal stromal/stem cells (MSCs) are a promising therapeutic agent for various diseases, including sepsis. However, translating MSC therapy to clinical applications remains challenging due to variations in the properties of MSCs under different preparation conditions. In this study, the gene expression profiles of human adipose-derived mesenchymal stromal/stem cells (ADSCs) under different culture conditions were compared in relation to their therapeutic efficacy for sepsis. Results showed that ADSCs cultured in media supplemented with human platelet lysates (hPL-ADSCs) exhibited a smaller cell size and higher proliferative capacity, while ADSCs cultured in media supplemented with fetal bovine serum (FBS-ADSCs) showed a broader and flatter shape. Both hPL-ADSCs and FBS-ADSCs exhibited a protective effect in a mouse model of sepsis; however, hPL-ADSCs displayed a better potency for immunosuppressive function, as evidenced by a better improvement of survival rate and further reduction of tissue injury and infectious biomarkers (ALT and PCT). Furthermore, hPL-ADSCs caused a more anti-inflammatory transcriptomic shift, while FBS-ADSCs led to more depression of pro-inflammatory transcriptomic response. This study thus demonstrates that both hPL-ADSCs and FBS-ADSCs are effective for anti-septic therapy via different mechanisms of inflammatory manipulation, although hPL-ADSCs may imply a better preference.Keywords
This publication has 49 references indexed in Scilit:
- Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated ViewMediators of Inflammation, 2013
- Mesenchymal Stromal Cells Improve Survival During Sepsis in the Absence of Heme Oxygenase-1: The Importance of NeutrophilsThe International Journal of Cell Cloning, 2012
- Immunomodulative Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells Cultured in Human Platelet LysateJournal of Clinical Immunology, 2011
- Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T‐ and NK‐cell proliferation and functionEuropean Journal of Immunology, 2011
- Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cellsHuman Immunology, 2010
- Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone MarrowThe International Journal of Cell Cloning, 2009
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric OxideCell Stem Cell, 2008
- Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch SignalingThe International Journal of Cell Cloning, 2007
- Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissuesCell and Tissue Banking, 2007
- FDA Regulation of Stem-Cell–Based TherapiesThe New England Journal of Medicine, 2006